Table 3.

Multivariable predictors of 90-day complications.

	Univariate OR (95% CI)	P value	Adjusted OR (95% CI)	P value
Age	0.99 (0.96–1.03)	0.71	0.97 (0.92–1.02)	0.20
Gender (referent female)	1.00 (0.43–2.34)	0.99	2.27 (0.77–6.76)	0.14
Charlson comorbidity index	1.38 (1.07–1.78)	0.014	1.34 (1.01–1.79)	0.045
Neoadjuvant chemotherapy	1.59 (0.59–4.27)	0.36	1.29 (0.40–4.16)	0.67
Total psoas area	0.82 (0.69–0.97)	0.019	0.70 (0.56–0.89)	0.003
Pathologic T Stage
T0	Referent	0.81	Referent	0.95
Ta	0.0	0.99	0.0	0.99
Tis	2.67 (0.19–36.76)	0.46	3.14 (0.12–83.74)	0.50
T1	1.25 (0.09–17.65)	0.87	1.84 (0.07–46.58)	0.71
T2	3.11 (0.25–39.54)	0.138	3.15 (0.14–73.16)	0.48
T3	2.73 (0.23–32.01)	0.43	3.92 (0.18–84.29)	0.38
T4	3.56 (0.28–44.88)	0.33	2.93 (0.13–64.55)	0.50
Node positive	1.76 (0.80–3.86)	0.16	1.68 (0.65–4.33)	0.29

OR: odds ratio, CI: confidence interval, and TPA: total psoas area.